The European Medicines Agency has set a 30 November deadline for marketing authorization holders (MAHs) who wish to submit minor variations to their marketing authorizations (MAs) and want the EMA to get the ball rolling on these before it closes for the Christmas and new year holiday period.
Key Takeaways
- Submitting type IA and type IA-IN variations for 2024 no later than 30 November will enable the European Medicines Agency to acknowledge the validity of...
It said that MAHs should submit type IA and type IA-IN variations for 2024 no later than the November deadline, as this would enable it to acknowledge the validity of...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?